Recently,every industry has been working to achieve carbon neutrality,and the wastewater sector is no exception.However,little research focuses on the carbon accounting of wastewater treatment and the roadmap to carbo...Recently,every industry has been working to achieve carbon neutrality,and the wastewater sector is no exception.However,little research focuses on the carbon accounting of wastewater treatment and the roadmap to carbon neutrality.Here,to systematically perform accounting,we provide a sketch that describes three boundaries of the wastewater system and propose that the carbon neutrality of the wastewater system is far beyond the plant boundary.Moreover,we identify the direct and indirect carbon emissions of wastewater treatment.In addition to direct emissions of CH_(4) and N_(2)O,direct fossil CO_(2) emissions from wastewater treatment should be included in accounting to set accurate guidelines.Next,the technologies that assist in achieving carbon-neutral wastewater treatment both within-thefence of wastewater treatment plants and beyond the plant boundary are summarized.All measurements of energy recovery,resource recovery,and water reuse contribute to reaching this goal.The concepts of energy neutrality and carbon neutrality are identified.Successful wastewater treatment cases in energy self-sufficiency may not achieve carbon neutrality.Meanwhile,resource recovery methods are encouraged,especially to produce carbon-based materials.Ultimately,the trend of preference for the decentralized sewage treatment system is pinpointed,and systematic thinking to set the urban infrastructure layout as a whole is advocated.展开更多
Eucommiae Cortex(EC),the dried stem bark of Eucommia ulmoides Oliv,has been traditionally used to strengthen the muscle and bone tissues and improve liver and kidney functions in East Asian countries,including China,J...Eucommiae Cortex(EC),the dried stem bark of Eucommia ulmoides Oliv,has been traditionally used to strengthen the muscle and bone tissues and improve liver and kidney functions in East Asian countries,including China,Japan,and Korea.Salty-fried EC(SFEC)is made by using mixing EC and saline together based on the protocol of Chinese Materia Medica Processing(CMMP)for clinical use.However,the clinical effectiveness of SFEC is directly impacted by the frying temperature and time.But precise techniques for evaluating the caliber of SFEC have yet to be developed.Thus,this study aimed to establish a fast and accurate quality-check method for SFEC decoction pieces.According to the frying temperature and time,four different categories of SFEC had been got according to the Chinese Pharmacopoeia method as Raw(R),Under(U),Moderately(M),and Overly(O).The red(R),green(G),blue(B),and light(L)color values of the decoction pieces were quantitated using the Photoshop software to determine the standard value range of the L color(raw[104.44±15.06],under[67.28±8.20],moderately[39.94±6.40],and over[15.02±5.03]).Additionally,the tensile strengths and pinoresinol diglucoside(PDG)levels of EC gum-silks were measured using the mechanical tensile test and HPLC,respectively.We also conducted Pearson correlation analysis on the L color value,EC gum-silk tension(FbcN),and PDG level,and established the following muliple-linear regression equation:the decline in PDG level(w)=0.829-0.001×FbeN-0.009×I.In conclusion,the L color value and FbeN could be used for cluster analysis of four categories of SFEC.Additinally,based on the correlation among the L color value,gum-silk tensile test,and PDG level,a rapid and accurate quality-control method for SFEC decoction pieces with different frying temperatures and durations was estab-lished.This method facilitates the manufacturing of efficacious SFEC.展开更多
With the improved efficacy and accessibility of antiviral agents as well as the concerns about disease progression,there is a hot discussion on whether HBeAg-negative chronic hepatitis B(CHB)patients with normal alani...With the improved efficacy and accessibility of antiviral agents as well as the concerns about disease progression,there is a hot discussion on whether HBeAg-negative chronic hepatitis B(CHB)patients with normal alanine aminotransferase(ALT)and positive HBV DNA should be treated.According to the international guidelines on the stages of the natural history of HBV infection,HBeAgnegative CHB patients with normal ALT and positive HBV DNA can be divided into two groups:one is the well-known“inactive carrier phase”,which is defined as serum HBV DNA<2000 IU/ml and no significant liver inflammation;and the other is the“indeterminate phase”,which is defined as serum HBV DNA≥2000 IU/mL regardless of the pathological changes in liver tissue,or HBV DNA<2000 IU/mL but accompanied by significant pathological changes in the liver.In this minireview,we will expound the disease characteristics,disease progression,and clinical management status of these two groups.Based on the analysis,we propose that HBeAg-negative patients with normal ALT but detectable serum HBV DNA should be treated,regardless of their age,family history of hepatocellular carcinoma(HCC)or the severity of liver necroinflammation.Expanding the indications of antiviral therapy will help improve the survival and quality of life of patients by preventing disease progression,and consequently reduce the risk of HCC development.展开更多
基金supported by Hubei Provincial Central Government Guided Local Science and Technology Development Special Project“Traditional Chinese Herbal Medicine Properties and Quality Evaluation Platform”(2020ZYYD030)Hubei Province Health and Family Planning Scientific Research Project(WJ2023Q016).
基金This work was supported by the National Natural Science Foundation of China(No.52070059).
文摘Recently,every industry has been working to achieve carbon neutrality,and the wastewater sector is no exception.However,little research focuses on the carbon accounting of wastewater treatment and the roadmap to carbon neutrality.Here,to systematically perform accounting,we provide a sketch that describes three boundaries of the wastewater system and propose that the carbon neutrality of the wastewater system is far beyond the plant boundary.Moreover,we identify the direct and indirect carbon emissions of wastewater treatment.In addition to direct emissions of CH_(4) and N_(2)O,direct fossil CO_(2) emissions from wastewater treatment should be included in accounting to set accurate guidelines.Next,the technologies that assist in achieving carbon-neutral wastewater treatment both within-thefence of wastewater treatment plants and beyond the plant boundary are summarized.All measurements of energy recovery,resource recovery,and water reuse contribute to reaching this goal.The concepts of energy neutrality and carbon neutrality are identified.Successful wastewater treatment cases in energy self-sufficiency may not achieve carbon neutrality.Meanwhile,resource recovery methods are encouraged,especially to produce carbon-based materials.Ultimately,the trend of preference for the decentralized sewage treatment system is pinpointed,and systematic thinking to set the urban infrastructure layout as a whole is advocated.
基金Hubei Provincial Central Government Guided Local Science and Technology Development Special Project“Traditional Chinese Herbal Medicine Properties and Quality Evaluation Platform”(2020ZYYD030)。
文摘Eucommiae Cortex(EC),the dried stem bark of Eucommia ulmoides Oliv,has been traditionally used to strengthen the muscle and bone tissues and improve liver and kidney functions in East Asian countries,including China,Japan,and Korea.Salty-fried EC(SFEC)is made by using mixing EC and saline together based on the protocol of Chinese Materia Medica Processing(CMMP)for clinical use.However,the clinical effectiveness of SFEC is directly impacted by the frying temperature and time.But precise techniques for evaluating the caliber of SFEC have yet to be developed.Thus,this study aimed to establish a fast and accurate quality-check method for SFEC decoction pieces.According to the frying temperature and time,four different categories of SFEC had been got according to the Chinese Pharmacopoeia method as Raw(R),Under(U),Moderately(M),and Overly(O).The red(R),green(G),blue(B),and light(L)color values of the decoction pieces were quantitated using the Photoshop software to determine the standard value range of the L color(raw[104.44±15.06],under[67.28±8.20],moderately[39.94±6.40],and over[15.02±5.03]).Additionally,the tensile strengths and pinoresinol diglucoside(PDG)levels of EC gum-silks were measured using the mechanical tensile test and HPLC,respectively.We also conducted Pearson correlation analysis on the L color value,EC gum-silk tension(FbcN),and PDG level,and established the following muliple-linear regression equation:the decline in PDG level(w)=0.829-0.001×FbeN-0.009×I.In conclusion,the L color value and FbeN could be used for cluster analysis of four categories of SFEC.Additinally,based on the correlation among the L color value,gum-silk tensile test,and PDG level,a rapid and accurate quality-control method for SFEC decoction pieces with different frying temperatures and durations was estab-lished.This method facilitates the manufacturing of efficacious SFEC.
基金supported by the National Natural Science Fundation of China(Grant No.30972622)the Clinical Research Incubation Project of West China Hospital of Sichuan University(Grant No.2022HXFH013).
文摘With the improved efficacy and accessibility of antiviral agents as well as the concerns about disease progression,there is a hot discussion on whether HBeAg-negative chronic hepatitis B(CHB)patients with normal alanine aminotransferase(ALT)and positive HBV DNA should be treated.According to the international guidelines on the stages of the natural history of HBV infection,HBeAgnegative CHB patients with normal ALT and positive HBV DNA can be divided into two groups:one is the well-known“inactive carrier phase”,which is defined as serum HBV DNA<2000 IU/ml and no significant liver inflammation;and the other is the“indeterminate phase”,which is defined as serum HBV DNA≥2000 IU/mL regardless of the pathological changes in liver tissue,or HBV DNA<2000 IU/mL but accompanied by significant pathological changes in the liver.In this minireview,we will expound the disease characteristics,disease progression,and clinical management status of these two groups.Based on the analysis,we propose that HBeAg-negative patients with normal ALT but detectable serum HBV DNA should be treated,regardless of their age,family history of hepatocellular carcinoma(HCC)or the severity of liver necroinflammation.Expanding the indications of antiviral therapy will help improve the survival and quality of life of patients by preventing disease progression,and consequently reduce the risk of HCC development.